|
08/02/2021
|
Summary ToggleEledon Pharmaceuticals to Release Second Quarter Financial Results on Thursday, August 12, 2021
|
|
07/26/2021
|
Summary ToggleEledon Pharmaceuticals Receives Health Canada Approval to Commence Human Trials to Evaluate AT-1501 in Kidney Transplantation
|
|
07/02/2021
|
Summary ToggleEledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors
|
|
06/29/2021
|
Summary ToggleEledon Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
|
|
05/18/2021
|
Summary ToggleEledon Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference
|
|
05/13/2021
|
Summary ToggleEledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
|
|
05/05/2021
|
Summary ToggleEledon Pharmaceuticals Announces Upcoming Presentations on AT-1501 at the Virtual 2021 American Transplant Congress
|
|
05/04/2021
|
Summary ToggleEledon Pharmaceuticals to Release First Quarter Financial Results on Thursday, May 13, 2021
|
|
04/26/2021
|
Summary ToggleEledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
|
|
04/19/2021
|
Summary ToggleEledon Pharmaceuticals Continues to Bolster Leadership Team with Addition of Two More Key Executives
|
